We chose SCCA2 because it had been reported that SCCA2 is dominantly expressed in lesional skin of psoriasis patients compared with SCCA1 [59,61], and because we had already established an ELISA kit specifically recognizing SCCA2 [24]. This evidence concerns the gene SERPINB4 and psoriasis.